Form 4 for IMMX Immix Biopharma, Inc.
Accepted 2025-12-10 00:00:00 ET · period of report 2025-12-10 · accession 0001493152-25-027109 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-10 | 2025-12-10 | IMMX | Rachman Ilya M | CEO, COB, Dir | P - Purchase | $6.67 | +746 | 1.14M | +0.1% | +$4,976 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-10 | P | A | 746 | $6.67 | 1,141,683 | D | — | — |